ClinicalTrials.govpublic full text
Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
breast cancer, stage iv breast cancer, recurrent breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804892
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.